Credit: Getty Images. The sBLA submission is supported by data from a phase 3 study that assessed the efficacy and safety of prophylactic treatment with Vonvendi in adults with severe VWD over a ...

Preemptive treatment strategies for pediatric RSV are discussed by key opinion leaders. Adam C. Welch, PharmD, MBA, FAPhA: So if these monoclonal antibodies are relatively short as far as the duration ...

ATLANTA--(BUSINESS WIRE)--A new study shows a clear association between the prophylactic use of five-layer foam sacral dressings and reductions in pressure injury rates. Specifically, the study looked ...

Community-site step-up dosing required proximity within 60 minutes, an adult caregiver for 48 hours, and twice-daily home temperature/SpO₂ checks with weekday clinic touchpoints. Prophylactic ...

Please provide your email address to receive an email when new articles are posted on . Of 1,196 tunneled catheters placed in nephrology services that use antibiotics, four resulted in bloodstream ...

Prevalence of vitamin D deficiency among palliative care cancer outpatients: Prospective analysis of 347 cases of single individual medical practice. This is an ASCO Meeting Abstract from the 2015 ...

Surrogate marker (SM) reporting in patients (pts) with advanced colorectal cancer (ACRC) of first-line clinical trials: It's time for standardized trial endpoint reporting. Molecular response to ...

The updated labeling is based on results from a safety management cohort from the ZUMA-1 study. The Food and Drug Administration (FDA) has approved updated labeling for Yescarta ® (axicabtagene ...

Please provide your email address to receive an email when new articles are posted on . Among experienced operators, prophylactic nitroglycerin did not prevent radial artery spasm during transradial ...

Lyme disease outcome and survival. Researchers conducted a meta-analysis to determine whether antibiotic prophylaxis is effective in the prevention of Lyme disease. The use of antibiotics as a ...

Patients hospitalized with COVID-19 who are treated with prophylactic anticoagulation have a lower risk of death at 30 days when compared with those who don’t receive anticoagulation, according to a ...